These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35477706)

  • 1. Foldamers reveal and validate therapeutic targets associated with toxic α-synuclein self-assembly.
    Ahmed J; Fitch TC; Donnelly CM; Joseph JA; Ball TD; Bassil MM; Son A; Zhang C; Ledreux A; Horowitz S; Qin Y; Paredes D; Kumar S
    Nat Commun; 2022 Apr; 13(1):2273. PubMed ID: 35477706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomimetically Engineered Amyloid-Shelled Gold Nanocomplexes for Discovering α-Synuclein Oligomer-Degrading Drugs.
    Lee D; Jung HG; Park D; Bang J; Hong JH; Lee SW; Roh S; Jang JW; Kim Y; Hwang KS; Lee YS; Park JY; Jung ID; Lee JH; Lee G; Yoon DS
    ACS Appl Mater Interfaces; 2023 Jan; 15(2):2538-2551. PubMed ID: 36548054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruptive membrane interactions of alpha-synuclein aggregates.
    Iyer A; Claessens MMAE
    Biochim Biophys Acta Proteins Proteom; 2019 May; 1867(5):468-482. PubMed ID: 30315896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson's disease: ex vivo and in vitro studies.
    Horvath I; Iashchishyn IA; Moskalenko RA; Wang C; Wärmländer SKTS; Wallin C; Gräslund A; Kovacs GG; Morozova-Roche LA
    J Neuroinflammation; 2018 Jun; 15(1):172. PubMed ID: 29866153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Library-Derived Peptide Aggregation Modulators of Parkinson's Disease Early-Onset α-Synuclein Variants.
    Watt KJC; Meade RM; Williams RJ; Mason JM
    ACS Chem Neurosci; 2022 Jun; 13(12):1790-1804. PubMed ID: 35613323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of alpha-synuclein aggregation by AM17, a synthetic resveratrol derivative.
    Chau E; Kim H; Shin J; Martinez A; Kim JR
    Biochem Biophys Res Commun; 2021 Oct; 574():85-90. PubMed ID: 34454326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining α-synuclein species responsible for Parkinson's disease phenotypes in mice.
    Froula JM; Castellana-Cruz M; Anabtawi NM; Camino JD; Chen SW; Thrasher DR; Freire J; Yazdi AA; Fleming S; Dobson CM; Kumita JR; Cremades N; Volpicelli-Daley LA
    J Biol Chem; 2019 Jul; 294(27):10392-10406. PubMed ID: 31142553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent effects of the H50Q and G51D SNCA mutations on the aggregation of α-synuclein.
    Rutherford NJ; Moore BD; Golde TE; Giasson BI
    J Neurochem; 2014 Dec; 131(6):859-67. PubMed ID: 24984882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synuclein Family Members Prevent Membrane Damage by Counteracting α-Synuclein Aggregation.
    Scheibe C; Karreman C; Schildknecht S; Leist M; Hauser K
    Biomolecules; 2021 Jul; 11(8):. PubMed ID: 34439733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exogenous Administration of Microsomes-associated Alpha-synuclein Aggregates to Primary Neurons As a Powerful Cell Model of Fibrils Formation.
    Panattoni G; Rota L; Colla E
    J Vis Exp; 2018 Jun; (136):. PubMed ID: 30010663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic modeling of α-synuclein aggregation in dopaminergic neuronal system indicates points of neuroprotective intervention: experimental validation with implications for Parkinson's therapy.
    Sultana Z; Paleologou KE; Al-Mansoori KM; Ardah MT; Singh N; Usmani S; Jiao H; Martin FL; Bharath MM; Vali S; El-Agnaf OM
    Neuroscience; 2011 Dec; 199():303-17. PubMed ID: 22056602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unveiling a Selective Mechanism for the Inhibition of α-Synuclein Aggregation by β-Synuclein.
    Leitao A; Bhumkar A; Hunter DJB; Gambin Y; Sierecki E
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29364143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-synuclein structure and Parkinson's disease - lessons and emerging principles.
    Meade RM; Fairlie DP; Mason JM
    Mol Neurodegener; 2019 Jul; 14(1):29. PubMed ID: 31331359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
    Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
    Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
    Ono K; Tsuji M; Yamasaki TR; Pasinetti GM
    Molecules; 2020 May; 25(10):. PubMed ID: 32456274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aggregation-defective alpha-synuclein mutants inhibit the fibrillation of Parkinson's disease-linked alpha-synuclein variants.
    Koo HJ; Choi MY; Im H
    Biochem Biophys Res Commun; 2009 Aug; 386(1):165-9. PubMed ID: 19501571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From a Highly Disordered to a Metastable State: Uncovering Insights of α-Synuclein.
    Cote Y; Delarue P; Scheraga HA; Senet P; Maisuradze GG
    ACS Chem Neurosci; 2018 May; 9(5):1051-1065. PubMed ID: 29451381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The release of toxic oligomers from α-synuclein fibrils induces dysfunction in neuronal cells.
    Cascella R; Chen SW; Bigi A; Camino JD; Xu CK; Dobson CM; Chiti F; Cremades N; Cecchi C
    Nat Commun; 2021 Mar; 12(1):1814. PubMed ID: 33753734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of αS Evolvability for Neuropathic Gaucher Disease.
    Wei J; Takamatsu Y; Wada R; Fujita M; Ho G; Masliah E; Hashimoto M
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33672048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants.
    Watt KJC; Meade RM; Williams RJ; Mason JM
    J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.